2026 annual financial data

PharmaCyte Biotech 2026 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -5,304,286 USD and net income was -19,424,654 USD.
Operating cash flow was -5,152,914 USD.

Get free PharmaCyte Biotech email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-5,304,286 USD
Net income
-19,424,654 USD
Operating cash flow
-5,152,914 USD